Completed NA INTERVENTIONAL 2-arm NCT01850758

Regenexx™ SD Versus Exercise Therapy for ACL Tears

A Randomized Controlled Trial of Regenexx™ SD Versus Exercise Therapy for Treatment of Partial and Complete, Non-retracted Anterior Cruciate Ligament Tears

Sponsor: Regenexx, LLC

Conditions Anterior Cruciate Ligament Tear

Interventions Exercise Therapy Regenexx SD

Updated 10 times since 2017 Last updated: Jul 6, 2022 Started: May 31, 2013 Primary completion: May 22, 2020 Completion: Mar 8, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anterior Cruciate Ligament Tear, this trial is completed. The trial is conducted by Regenexx, LLC and has accumulated 10 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Feb 2022 — Sep 2022 [monthly]

Active Not Recruiting NA
Jan 2021 — Feb 2022 [monthly]

Active Not Recruiting NA

▶ Show 5 earlier versions

Sep 2020 — Jan 2021 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
May 2019 — Sep 2020 [monthly]

Recruiting NA
Aug 2018 — May 2019 [monthly]

Recruiting NA
Jun 2018 — Aug 2018 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regenexx, LLC

Data source: Regenexx, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Broomfield, United States